[{"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67935", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1261-2014", "product_description": "Potassium Chloride for Inj. Concentrate, USP, 40 mEq (2  mEq/mL), 20 mL Single-dose Fliptop Vial, For IV use, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA", "product_quantity": "255,900 vials", "reason_for_recall": "Presence of Particulate; red and black particulate within the solution and embedded within the plastic vial identified as iron oxide", "recall_initiation_date": "20140327", "center_classification_date": "20140424", "termination_date": "20150630", "report_date": "20140430", "code_info": "Lot 22-127-DK", "more_code_info": ""}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65154", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.", "recall_number": "D-433-2013", "product_description": "Lloyd Thyro-Tab 0.050 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX.  The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "7,681,277 tablets", "reason_for_recall": "cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.", "recall_initiation_date": "20130401", "center_classification_date": "20130521", "termination_date": "20140508", "report_date": "20130529", "code_info": "Lot #: HB04712, Exp. Mar-13, HB08112, HC08112, Exp Apr-13, and HC11112 May-13."}, {"status": "Terminated", "city": "Tinton Falls", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "64640", "recalling_firm": "Med Prep Consulting, Inc.", "address_1": "1540 W Park Ave Ste 5", "address_2": "N/A", "postal_code": "07712-3192", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Press States Nationwide. Distribution List indicates the following:    DE, FL, IL,  IN, ME, MI, NJ, PA, TX, and VA", "recall_number": "D-810-2013", "product_description": "Magnesium Sulfate 2 grams in Dextrose 5% for Injection, in 50 mL Plastic Infusion Bags, Med Prep Consulting Inc., Tinton Falls, NJ 07712", "product_quantity": "403883 bags", "reason_for_recall": "Non-Sterility; mold contamination", "recall_initiation_date": "20130314", "center_classification_date": "20130719", "termination_date": "20180511", "report_date": "20130731", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Chatsworth", "state": "CA", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89949", "recalling_firm": "Pink Toyz", "address_1": "9180 Gazette Ave", "address_2": "", "postal_code": "91311-5917", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA via walmart.com online marketplace", "recall_number": "D-0785-2022", "product_description": "Pink Pussycat SENSUAL ENHANCEMENT capsule, 3000mg, 1-count blister card, Manufactured for: Pink Pussycat Products - Chatsworth, CA  91311, UPC 8 91875 00462 6.", "product_quantity": "120 blister cards", "reason_for_recall": "Marketed Without An Approved NDA/ANDA: FDA analysis found the product to contain undeclared sildenafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.", "recall_initiation_date": "20220329", "center_classification_date": "20220425", "termination_date": "20240731", "report_date": "20220427", "code_info": "Lot: 2009066, Exp: 09/2023", "more_code_info": ""}, {"country": "United States", "city": "Suffern", "address_1": "25 Old Mill Rd", "reason_for_recall": "Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.", "address_2": "", "product_quantity": "12,6245 bottles", "code_info": "Product code: 708236; Lot Number: F0116, F0116W1, F0016W2, Exp 09/30/2013; F0117, Exp 02/28/2014; F0118, 6) F0119, Exp 08/31/2014", "center_classification_date": "20131206", "distribution_pattern": "Nationwide and Puerto Rico", "state": "NY", "product_description": "Tekturna (aliskiren) Tablets 150 mg, 7 tablets per bottle, Physician Sample-Not For Sale, Rx only.  Manufactured by: Novartis Pharma Productions GmbH Wehr, Germany.  Distributed by: Novartis Pharmaceuticals Corp. East Hanover, New Jersey 07936, NDC # 0078-9485-07", "report_date": "20131218", "classification": "Class II", "openfda": {}, "recalling_firm": "Novartis Pharmaceuticals Corp.", "recall_number": "D-337-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "66015", "termination_date": "20151221", "more_code_info": "", "recall_initiation_date": "20130808", "postal_code": "10901-4106", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Phoenix", "address_1": "24416 N 19th Ave", "reason_for_recall": "Lack of Assurance of Sterility: Potential leakage of bags.", "address_2": "", "product_quantity": "20 bags", "code_info": "Lot 5/14/18 0722 47-00287Y EXP 06/28/2018", "center_classification_date": "20180719", "distribution_pattern": "Nationwide in the USA", "state": "AZ", "product_description": "0.2% ROPivacaine, (Ropivacaine HCL PF, USP 500mg, 0.9% Sodium Chloride, USP QS 250 mL). Volume 250 mL. Single dose Cassette. For: Parkland Memorial Hospital. By: Advanced Pharma, 9225 Kirby Dr. Houston, TX 77054. Parkland Memorial Hospital NDC 15082-002-87", "report_date": "20180725", "classification": "Class II", "openfda": {}, "recalling_firm": "Avella of Deer Valley, Inc. Store 38", "recall_number": "D-0942-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "80307", "termination_date": "20200124", "more_code_info": "", "recall_initiation_date": "20180612", "postal_code": "85085-1887", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0192-2018", "product_description": "Savinase 100 mcg/mL Topical Solution, 1 mL in a 3 mL Droptainer, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "30 droptainers", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lot: 06262017@31 BUD: 6/26/2018", "more_code_info": ""}, {"status": "Terminated", "city": "Morristown", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "65702", "recalling_firm": "Bayer HealthCare Pharmaceuticals Inc.", "address_1": "36 Columbia Rd", "address_2": "N/A", "postal_code": "07960-4526", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY, CA", "recall_number": "D-807-2013", "product_description": "Medroxyprogesterone acetate, micronized (EP, USP) active pharmaceutical ingredient, Rx only, packaged in 6.0 kg drums (labeled as 6,000 kg), Bayer Schering Pharma AG, D-13342 Berlin", "product_quantity": "194.62 kg", "reason_for_recall": "Failed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.", "recall_initiation_date": "20130613", "center_classification_date": "20130718", "termination_date": "20140210", "report_date": "20130724", "code_info": "Lot 87100040"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73925", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0053-2017", "product_description": "ketamine HCl, 10 mg per mL, 50 mg per 5 mL, in 0.9% Sodium Chloride, 5 mL Total Volume in a syringe, For IV Use, Rx only, PharMEDium, Product code 2R3234.", "product_quantity": "25 syringes", "reason_for_recall": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.", "recall_initiation_date": "20150717", "center_classification_date": "20161012", "termination_date": "20170623", "report_date": "20161019", "code_info": "Lot Number: 15112064M, Exp between 07/15/15-10/12/15"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0180-2022", "product_description": "TESTOSTERONE CYPIONATE 200MG/ML INJ #2 IN SESAME OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "43 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T1007082021:20 BUD: 01/04/2022; T0907262021:21 BUD: 01/04/2022; T0506142021:81 BUD: 12/11/2021; T104142021:49 BUD: 10/11/2021; T1006022021:96 BUD: 11/29/2021; T0507152021:79 BUD: 01/11/2022; T1009082021:42 BUD: 03/07/2022; T0508172021:37 BUD: 02/13/2022; T0505112021:57 BUD: 10/11/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73925", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0052-2017", "product_description": "HYDROmorphone HCl, 1 mg per mL, in 0.9% Sodium Chloride, 1 mL Total Volume in a syringe, For IV Use, Rx only, PharMEDium, Product code 2T6165", "product_quantity": "450 syringes", "reason_for_recall": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.", "recall_initiation_date": "20150717", "center_classification_date": "20161012", "termination_date": "20170623", "report_date": "20161019", "code_info": "Lot Numbers: 15133058M, 15140061M, 15147056M, 151880295M, Exp between 07/15/15-10/12/15"}, {"country": "United States", "city": "Springerville", "address_1": "105 W Main St", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "1 container", "code_info": "all lots", "center_classification_date": "20151201", "distribution_pattern": "Nationwide in US: Arizona, California, Georgia, New Mexico, South Carolina, South Dakota, Texas, and Utah", "state": "AZ", "product_description": "Podophyllum 40% Topical, Rx, Western Drug Inc. 106 E. Main Street, Springerville, Arizona 85938", "report_date": "20151209", "classification": "Class II", "openfda": {}, "recalling_firm": "Western Drug", "recall_number": "D-0442-2016", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "72520", "termination_date": "20161001", "more_code_info": "", "recall_initiation_date": "20151019", "postal_code": "85938-7203", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0023-2024", "product_description": "fentaNYL, 5,000 mcg/100 mL, (50 mcg/mL), 100 mL Bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-5", "product_quantity": "71 100 mL bags", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot:17-275322, Exp. 10/3/2023."}, {"status": "Ongoing", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87941", "recalling_firm": "Global Sanitizers LLC", "address_1": "5979 S Valley View Blvd", "address_2": "N/A", "postal_code": "89118-3111", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product Distributed Nationwide in the USA", "recall_number": "D-0780-2021", "product_description": "MEDICALLY MINDED Hand Sanitizer Gel, ANTIMICROBIAL FORMULA, (Ethyl Alcohol 70% v/v), 8 FL OZ (236 mL) bottle, Manufactured by Asiaticon, S.A. de C.V. Conkal 62, Jardines del Ajusco, Tlalpan, Ciudad de Mexico, C.P. 14200, Distributed by SBL Brands, LLC. Las Vegas, NV 89119. Made in Mexico UPC: 6 76753 00420 8,", "product_quantity": "50,000 bottles", "reason_for_recall": "Chemical Contamination: FDA analysis found 1 lot of MEDICALLY MINDED Hand Sanitizer Gel, ANTIMICROBIAL FORMULA (ethyl alcohol 70%) to be below the label claim for ethanol content and to contain methanol.", "recall_initiation_date": "20210512", "center_classification_date": "20210830", "report_date": "20210908", "code_info": "Lot No: E082020, \"Best Buy\": 5/21/2022"}, {"status": "Ongoing", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA079019"], "brand_name": ["ATOMOXETINE"], "generic_name": ["ATOMOXETINE"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-265", "68462-266", "68462-267", "68462-268", "68462-269", "68462-270", "68462-271"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATOMOXETINE HYDROCHLORIDE"], "rxcui": ["349591", "349592", "349593", "349594", "349595", "608139", "608143"], "spl_id": ["84dc1413-a85b-41f6-a3e3-6e76c01f6803"], "spl_set_id": ["0ab8d905-e890-4e91-a730-3e5d12f5c23f"], "package_ndc": ["68462-265-30", "68462-265-23", "68462-266-30", "68462-266-23", "68462-267-30", "68462-267-23", "68462-268-30", "68462-268-23", "68462-269-30", "68462-269-23", "68462-270-30", "68462-270-23", "68462-271-30", "68462-271-51"], "is_original_packager": [true], "upc": ["0368462270301"], "unii": ["57WVB6I2W0"]}, "product_type": "Drugs", "event_id": "96194", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "N/A", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S", "recall_number": "D-0236-2025", "product_description": "Atomoxetine Capsules, USP, 80 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-270-30.", "product_quantity": "87,600 bottles", "reason_for_recall": "CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.", "recall_initiation_date": "20250129", "center_classification_date": "20250220", "report_date": "20250226", "code_info": "Lot Numbers: 19234153, Exp.: 9/2025; 19234900, 19234929, Exp.: 11/2025; 19240936, 19240942, Exp.: 2/2026; 19243199, 19243190, Exp.:7/2026; 19244013, 19244014, Exp.: 9/2026."}, {"status": "Completed", "city": "Somerset", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203072"], "brand_name": ["IRBESARTAN AND HYDROCHLOROTHIAZIDE"], "generic_name": ["IRBESARTAN AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Solco Healthcare US, LLC"], "product_ndc": ["43547-330", "43547-331"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "IRBESARTAN"], "rxcui": ["310792", "310793"], "spl_id": ["13ddf1e5-56aa-45f2-b7b7-a91c24d8c0b3"], "spl_set_id": ["72fa8cd4-bc2a-4a7d-8feb-2d60e077d801"], "package_ndc": ["43547-330-03", "43547-330-09", "43547-330-50", "43547-331-03", "43547-331-09", "43547-331-50"], "is_original_packager": [true], "upc": ["0343547331030", "0343547330033"], "nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "unii": ["0J48LPH2TH", "J0E2756Z7N"]}, "product_type": "Drugs", "event_id": "81910", "recalling_firm": "Prinston Pharmaceutical Inc", "address_1": "700 Atrium Dr", "address_2": "N/A", "postal_code": "08873-4107", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0411-2019", "product_description": "Irbesartan and Hydrochlorothiazide Tablets, USP 300/12.5 mg Rx Only Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Xunqiao, Linhai, Zheijang 317024, China   Distributed by: Solco Healthcare US, LLC Cranbury, NJ 08512  30 count - NDC 43547-331-03", "product_quantity": "32692 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.", "recall_initiation_date": "20190118", "center_classification_date": "20190127", "report_date": "20190206", "code_info": "327A18001  327A18002"}, {"status": "Ongoing", "city": "Louisville", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96853", "recalling_firm": "KABANA SKIN CARE", "address_1": "685 S Arthur Ave Unit 9b", "address_2": "N/A", "postal_code": "80027-3141", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NJ, FL, MI", "recall_number": "D-0514-2025", "product_description": "GreenScreen, kabana organic skincare, Bread Spectrum UVA & UVB, Zinc Oxide Sunscreen, Organic Ingredients, Fragrance Free, Biodegradable, Chemical Free, Non-Nano, Baby Safe, Original, SPF 32, Totally Green personal care, Zinc Oxide USP 25%, 3.4 FL OZ/115 G Tube, NDC: 73369-0001-1", "product_quantity": "174 tubes", "reason_for_recall": "cGMP deviations", "recall_initiation_date": "20250312", "center_classification_date": "20250710", "report_date": "20250716", "code_info": "Lots: 405-002 and 405-003", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72594", "recalling_firm": "Walgreens Infusion Services", "address_1": "14220 Northbrook Dr Ste 100B", "address_2": "N/A", "postal_code": "78232-5045", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas", "recall_number": "D-0535-2016", "product_description": "0.9% NaCl 1000 mL with Ca 4.65 meq bag, Rx Only, Compounded by Option Care 148, San Antonio, TX 78232-5045", "product_quantity": "7 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151110", "center_classification_date": "20151230", "termination_date": "20171018", "report_date": "20160106", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Ft Lauderdale", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "66043", "recalling_firm": "Fabscout Entertainment, Inc", "address_1": "1458 NW 23rd Ave", "address_2": "N/A", "postal_code": "33311-5147", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "CA, FL and UT", "recall_number": "D-377-2014", "product_description": "72HP MAXIMUM POTENCY MALE SEXUAL ENHANCEMENT, Dietary Supplement, supplied in 1 capsule per blister pack, Distributed by: 72HP, Inc. Weston, FL", "product_quantity": "578 blister packs of 1 capsule each", "reason_for_recall": "Marketed without an Approved NDA/ANDA: products were found to contain undeclared sildenafil", "recall_initiation_date": "20130814", "center_classification_date": "20131218", "termination_date": "20210210", "report_date": "20131225", "code_info": "All Lots"}, {"status": "Terminated", "city": "Morgantown", "state": "WV", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA202771"], "brand_name": ["NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL"], "generic_name": ["NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-7280"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ETHINYL ESTRADIOL", "NORETHINDRONE ACETATE"], "rxcui": ["1358762", "1358776"], "spl_id": ["e450353d-021c-b48d-d1ea-0787a1561ae2"], "spl_set_id": ["89948751-bd6e-4e9c-b87c-8782706c1097"], "package_ndc": ["0378-7280-85", "0378-7280-53"], "is_original_packager": [true], "nui": ["N0000175825", "N0000000100"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["423D2T571U", "9S44LIC7OJ"]}, "product_type": "Drugs", "event_id": "77065", "recalling_firm": "Mylan Pharmaceuticals Inc.", "address_1": "781 Chestnut Ridge Rd", "address_2": "", "postal_code": "26505-2730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in USA", "recall_number": "D-0861-2017", "product_description": "Norethindrone Acetate and Ethinyl Estradiol Tablets, USP, 1 mg/0.02 mg, 1 blister pack containing 21 tablets (NDC 0378-7280-85), packaged in 3 pouches, each contains one blister pack of 21 tablets (NDC 0378-7280-53), Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV  26505 U.S.A., Made in India.", "product_quantity": "8,605 cartons", "reason_for_recall": "Chemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint thinner used in repair of the manufacturing room.", "recall_initiation_date": "20170130", "center_classification_date": "20170523", "termination_date": "20170601", "report_date": "20170531", "code_info": "Lot #: 6327A006, Exp 02/18", "more_code_info": ""}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93103", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0027-2024", "product_description": "HYDROmorphone in 0.9% sodium chloride, 6 mg/30 mL, (0.2 mg/mL), 30 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2010-1", "product_quantity": "1,190 30 mL syringes", "reason_for_recall": "Lack of assurance of sterility:", "recall_initiation_date": "20230921", "center_classification_date": "20231004", "termination_date": "20250319", "report_date": "20231011", "code_info": "Lot:17-275680, Exp. 10/8/2023; 17-275945, Exp. 10/13/2023; 17-276094, Exp. 10/17/2023"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-767-2015", "product_description": "Lodenafil Carbonate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "100 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78791", "recalling_firm": "SHISEIDO AMERICA INC.", "address_1": "366 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1411", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide.", "recall_number": "D-0215-2018", "product_description": "Shiseido Future Solution LX Universal Defense SPF 50+ (octinoxate 4.9%, octocrylebe 3.0%, oxybenzone 1.0% and zinc oxide 15.4%), packaged in a) 2mL, b) 15 mL and c) 50 mL tubes, Shiseido Americas Corporation Dist. New York, NY 10022. NDC 58411-256-60", "product_quantity": "N/A", "reason_for_recall": "GMP Deviations: manufacturing of API material did not meet GMP and quality requirements.", "recall_initiation_date": "20171214", "center_classification_date": "20180112", "termination_date": "20210624", "report_date": "20180124", "code_info": "SKU#:  a) 8C52541, b) 8B41841, c) 1155840, 1155841, 1155842, 1155851,  0710341, 0710342"}, {"status": "Ongoing", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96033", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0202-2025", "product_description": "glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11", "product_quantity": "2,028 units (cartons of 30 individual unit doses)", "reason_for_recall": "Failed Dissolution Specifications:", "recall_initiation_date": "20241217", "center_classification_date": "20250116", "report_date": "20250122", "code_info": "Lot # 1012910, Exp Date: 04/30/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70118", "recalling_firm": "Walgreens Infusion Services", "address_1": "9030 Kirby Dr", "address_2": "N/A", "postal_code": "77054-2504", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Texas, Florida, Virginia, Georgia, Louisiana, Mississippi", "recall_number": "D-0361-2015", "product_description": "Acyclovir various strengths in normal saline", "product_quantity": "N/A", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20141226", "center_classification_date": "20150116", "termination_date": "20150724", "report_date": "20150128", "code_info": "All products within expiry."}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92253", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "6580 Snowdrift Rd Ste 100", "address_2": "N/A", "postal_code": "18106-9331", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0655-2023", "product_description": "Cardioplegia Solution, Warm Induction 4:1 HIGH POTASSIUM/low tromethamine, 40 mEq K, packaged in 500 mL per bag, Rx only, Central Admixture Pharmacy Services, Inc., Lehigh Valley, 6580 Snowdrift Road, Allentown, PA  18106, NDC 71285-0011-1.", "product_quantity": "12 bags", "reason_for_recall": "Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.", "recall_initiation_date": "20230428", "center_classification_date": "20230519", "termination_date": "20250622", "report_date": "20230531", "code_info": "Lot # 37-897075, Exp 05/11/2023"}, {"status": "Terminated", "city": "Ronkonkoma", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091239"], "brand_name": ["VALUMEDS IBUPROFEN"], "generic_name": ["IBUPROFEN"], "manufacturer_name": ["SPIRIT PHARMACEUTICALS LLC"], "product_ndc": ["68210-0800"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["310965"], "spl_id": ["28ed10e2-9113-a062-e063-6394a90a0ba3"], "spl_set_id": ["a6d4ceb0-2b79-496a-aa1e-27edd507ced0"], "package_ndc": ["68210-0800-1", "68210-0800-4"], "is_original_packager": [true], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "79361", "recalling_firm": "Spirit Pharmaceuticals, LLC", "address_1": "2004 Orville Dr N Ste 2", "address_2": "N/A", "postal_code": "11779-7645", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY", "recall_number": "D-0583-2018", "product_description": "Ibuprofen Tablets USP, 200 mg, 100-count bottles, OTC, Distributed By: Spirit Pharmaceuticals, LLC Ronkonkoma, NY 11779, NDC 68210-0800-1", "product_quantity": "144 bottles", "reason_for_recall": "CGMP deviations: Ibuprofen is being recalled in response to previous recall", "recall_initiation_date": "20180110", "center_classification_date": "20180309", "termination_date": "20210120", "report_date": "20180314", "code_info": "Lot#: HJ6138"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-761-2015", "product_description": "Levothyroxine Sodium (T4) active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "4605 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Ongoing", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87941", "recalling_firm": "Global Sanitizers LLC", "address_1": "5979 S Valley View Blvd", "address_2": "N/A", "postal_code": "89118-3111", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product Distributed Nationwide in the USA", "recall_number": "D-0779-2021", "product_description": "MEDICALLY MINDED Hand Sanitizer Gel, ANTIMICROBIAL FORMULA, (Ethyl Alcohol 70% v/v),  8.5 FL OZ  (250 mL) bottle, Manufactured by Asiaticon, S.A. de C.V. Conkal 62, Jardines del Ajusco, Tlalpan, Ciudad de Mexico, C.P. 14200, Distributed by SBL Brands, LLC. Las Vegas, NV 89119. Made in Mexico UPC 6 76753 00414 7", "product_quantity": "50,000 bottles", "reason_for_recall": "CGMP Deviations:  lots and products of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.", "recall_initiation_date": "20210512", "center_classification_date": "20210830", "report_date": "20210908", "code_info": "Lot No: E372020, \"Best Buy\": 5/21/2022;"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78828", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0428-2018", "product_description": "HYDROmorphone HCl in Sodium Chloride 0.9% in all doses, all strengths, and all packaging.", "product_quantity": "Unknown", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20171227", "center_classification_date": "20180220", "termination_date": "20200507", "report_date": "20180228", "code_info": "All lots remaining within expiry."}, {"country": "United States", "city": "Monmouth Junction", "address_1": "2033 US Highway 130", "reason_for_recall": "Superpotent Drug: recalled lots may have higher concentration of ibuprofen.", "address_2": "", "product_quantity": "164,304 bottles", "code_info": "Lot #: 00717009A, Exp 02/19; 00717015A, Exp 04/19; 00717024A, Exp 08/19", "center_classification_date": "20181217", "distribution_pattern": "One distributor in PA who further distributed Nationwide in the USA.", "state": "NJ", "product_description": "infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-23,  UPC 0 78742 02016 7.", "report_date": "20181226", "classification": "Class II", "openfda": {}, "recalling_firm": "Tris Pharma Inc.", "recall_number": "D-0335-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81354", "termination_date": "20210401", "more_code_info": "", "recall_initiation_date": "20181126", "postal_code": "08852-3003", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021514"], "brand_name": ["DAYTRANA"], "generic_name": ["METHYLPHENIDATE"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-5552", "68968-5553", "68968-5554", "68968-5555"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["METHYLPHENIDATE"], "rxcui": ["753436", "753437", "753438", "753439", "753440", "753441", "753442", "753443"], "spl_id": ["55f4b5f4-6d3c-4677-a94c-d47ffb59a91a"], "spl_set_id": ["2c312c31-3198-4775-91ab-294e0b4b9e7f"], "package_ndc": ["68968-5552-3", "68968-5553-3", "68968-5554-3", "68968-5555-3"], "is_original_packager": [true], "nui": ["N0000175739", "N0000175729"], "pharm_class_epc": ["Central Nervous System Stimulant [EPC]"], "pharm_class_pe": ["Central Nervous System Stimulation [PE]"], "unii": ["207ZZ9QZ49"]}, "product_type": "Drugs", "event_id": "67718", "recalling_firm": "Noven Pharmaceuticals, Inc.", "address_1": "11960 Sw 144th St", "address_2": "", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1172-2014", "product_description": "Daytrana (methylphenidate) transdermal system patch, Delivers 30 mg over 9 hours (3.3mg/hr), 1patch per pouch , packaged in 30-count patches per box, Rx Only.Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc., Miami, FL 33186. NDC 68968-5555-3.", "product_quantity": "117,600 patches", "reason_for_recall": "Defective Delivery System: Out of Specification (OOS) results for the z-statistic value, which relates to the patients and caregiver ability to remove the release liner from the patch adhesive prior to administration, were obtained.", "recall_initiation_date": "20140213", "center_classification_date": "20140320", "termination_date": "20190319", "report_date": "20140326", "code_info": "Lot #70132, Exp. 09/14", "more_code_info": ""}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0306-2023", "product_description": "METRONIDAZOLE 500MG 100ML, antibiotic, Rx Only, use with a home pump or no pump, Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320", "product_quantity": "30 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 24-29, 2022"}, {"status": "Terminated", "city": "Brampton", "state": "", "country": "Canada", "classification": "Class II", "openfda": {"application_number": ["ANDA074904"], "brand_name": ["DESOXIMETASONE"], "generic_name": ["DESOXIMETASONE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["51672-1261", "51672-1271", "51672-1270"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["DESOXIMETASONE"], "rxcui": ["197573", "197574", "315059"], "spl_id": ["38f63e0c-c4d2-523e-e063-6394a90a0272"], "spl_set_id": ["37eb1205-1743-4480-8631-b0bbcaeb8359"], "package_ndc": ["51672-1271-1", "51672-1271-2", "51672-1271-3", "51672-1271-7", "51672-1270-1", "51672-1270-2", "51672-1270-3", "51672-1270-7", "51672-1261-1", "51672-1261-2", "51672-1261-3"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["4E07GXB7AU"]}, "product_type": "Drugs", "event_id": "75349", "recalling_firm": "Taro Pharmaceuticals, Inc.", "address_1": "130 East Dr", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US & Puerto Rico", "recall_number": "D-0116-2017", "product_description": "Desoximetasone Cream USP, 0.25% 100 g, Rx only, mfd. by Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc. Hawthorne, NY 10532; NDC 51672-1270-7", "product_quantity": "15,576 units", "reason_for_recall": "Failed Stability Specifications: The subject lots exhibited OOS results for Homogeneity test (Moderate separation).", "recall_initiation_date": "20160913", "center_classification_date": "20161101", "termination_date": "20180615", "report_date": "20161109", "code_info": "Lot #: B5093-18608, B5094-18608,  Exp. Jan 2017; Lot #: C5141-18954, C5142-18954, E5109-19625,  Exp . Feb 2017", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1117-2020", "product_description": "Dermatoxin, 500mg Capsules, 90-count bottles, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1177-2020", "product_description": "Fluorouracil (5-FU) 4.5% Cream 100 GM, tube Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 tube", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45044 Discard by: 8/2/2020", "more_code_info": ""}, {"status": "Terminated", "city": "Corona", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67200", "recalling_firm": "Watson Laboratories Inc", "address_1": "132 Business Center Dr", "address_2": "", "postal_code": "92880-1724", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-397-2014", "product_description": "Carisoprodol Tablets, USP, CIV, 350 mg, 500 count bottle, Rx only. Manufactured by Watson Pharma Private Ltd, Verna, Salcette, Goa, 403 722 INDIA.  Distributed by: Watson Pharma Ltd, Parsippany, NJ 07054. NDC 0591-5513-05.", "product_quantity": "4,439 bottles", "reason_for_recall": "Presence of Foreign Substance; metal particulates were visually observed in the tablets.", "recall_initiation_date": "20131223", "center_classification_date": "20140106", "termination_date": "20140804", "report_date": "20140115", "code_info": "Lot # 244152A, exp 01/15.", "more_code_info": ""}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0672-2019", "product_description": "Dr. King's Natural Medicine for kids! Newborn Tonic Homeopathic, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside dr. Asheville, NC 28806 USA, UPC 357955511427, NDC 57955-5114-2", "product_quantity": "84 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 063016K Exp. 06/2019; 112315F Exp. 11/2018"}, {"status": "Completed", "city": "Ridgeland", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90798", "recalling_firm": "Carolina Infusion", "address_1": "95 Bees Creek Rd", "address_2": "", "postal_code": "29936-7540", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1517-2022", "product_description": "MIC/B12/L-Carn (HD) 35/35/35/1/35 MG/ML Injectable, 10 ML vial, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.", "product_quantity": "4 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20220826", "center_classification_date": "20220915", "report_date": "20220921", "code_info": "Lots: 05042022@4 BUD: 10/31/2022; 062920222@9 BUD: 12/26/2022; 07262022@3 BUD: 01/22/2023", "more_code_info": ""}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "144 pellets", "code_info": "All lots distributed between November 2014 and May 2015;    11262014@67, 5/25/2015; 03022015@70, 8/29/2015; 01052015@50, 7/4/2015; 02052015@72, 8/4/2015; 04302015@53, 10/27/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Testosterone 12.5 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1743-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Houston", "address_1": "9265 Kirby Dr", "reason_for_recall": "Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.", "address_2": "", "product_quantity": "", "code_info": "all lots within expiry", "center_classification_date": "20170523", "distribution_pattern": "U.S. Nationwide", "state": "TX", "product_description": "Epinephrine HCl all strengths, all dosage forms and all packaging, Rx  Only, Avella of Houston, Houston, TX 77054", "report_date": "20170531", "classification": "Class II", "openfda": {}, "recalling_firm": "Advanced Pharma Inc.", "recall_number": "D-0828-2017", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "76561", "termination_date": "20171018", "more_code_info": "", "recall_initiation_date": "20170222", "postal_code": "77054-2520", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ferndale", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "67723", "recalling_firm": "Terra-Medica Inc.", "address_1": "1465 Slater Rd", "address_2": "N/A", "postal_code": "98248-8919", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Products were distributed US Nationwide, to Canada, to Philippines, and through internet sales.", "recall_number": "D-1201-2014", "product_description": "Pleo Quent CAPSULES 4X, 20 Capsule Cartons, Oral Homeopathic Medicine, OTC Only.  Made in Germany for: SANUM USA Copr, 1456 Slater Road, Ferndale, WA 98248 by Sanum-Kehlbeck GmbH & Co. KG NDC: 49807-2902-1.", "product_quantity": "3066 cartons", "reason_for_recall": "Penicillin Cross Contamination", "recall_initiation_date": "20140303", "center_classification_date": "20140407", "termination_date": "20140730", "report_date": "20140416", "code_info": "Batch # 25030; EXP: April  2015; Batch # 27101, EXP: Sept 2016."}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA213338"], "brand_name": ["DOFETILIDE"], "generic_name": ["DOFETILIDE"], "manufacturer_name": ["Accord Healthcare, Inc."], "product_ndc": ["16729-490", "16729-491", "16729-492"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOFETILIDE"], "rxcui": ["310003", "310004", "310005"], "spl_id": ["40bca241-47f2-b7f0-e063-6294a90a1680"], "spl_set_id": ["4c1a5a6d-bd69-473c-8caa-d0d242b7708d"], "package_ndc": ["16729-490-12", "16729-490-59", "16729-491-12", "16729-491-59", "16729-492-12", "16729-492-59"], "is_original_packager": [true], "nui": ["N0000175426"], "pharm_class_epc": ["Antiarrhythmic [EPC]"], "unii": ["R4Z9X1N2ND"], "upc": ["316729491129"]}, "product_type": "Drugs", "event_id": "91657", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States including Puerto Rico and Canada", "recall_number": "D-0384-2023", "product_description": "Dofetilide Capsules 250 mcg (0.25 mg) 60-count bottle, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703.  Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213, INDIA NDC 16729-491-12 UPC 3 16729 49112 9", "product_quantity": "113,571 bottles", "reason_for_recall": "CGMP Deviations: recalling drug products following an FDA inspection.", "recall_initiation_date": "20230207", "center_classification_date": "20230302", "termination_date": "20240422", "report_date": "20230308", "code_info": "Batches: P2101481 Exp. Date 2/28/2023; P2101985, P2101958, P2102019, Exp. Date 3/31/2023; P2102580, P2102597, Exp. Date 4/30/2023; P2104708, P2104712, Exp. Date 6/30/2023; P2107154,  P2107187, Exp. Date 10/31/2023; P2107874, Exp. Date 11/30/2023; P2200772,  P2200796,  P2200830, Exp. Date 12/31/2023; P2201196,  P2201198, Exp. Date 1/31/2024; P2200817, Exp. Date 12/31/2024; P2202610, Exp. Date 4/30/2025; P2203466, Exp. Date 5/31/2025;", "more_code_info": ""}, {"status": "Terminated", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78240", "recalling_firm": "AVKARE Inc.", "address_1": "615 N 1st St", "address_2": "N/A", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0055-2018", "product_description": "Duloxetine Delayed-release Capsules USP, 20 mg, 50 Capsules (5 x 10) Unit Dose per carton, unit dose blister UPC 5026828311), Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-283-15.", "product_quantity": "274 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid.", "recall_initiation_date": "20171006", "center_classification_date": "20171027", "termination_date": "20190311", "report_date": "20171108", "code_info": "Lot: 18103 Exp. 11/18"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1017-2022", "product_description": "GlucaGen (glucagon) for injection, 1 mg per vial, single dose kit, Rx only, Manufactured for: Boehringer Mannheim, NDC 0597-0260-10", "product_quantity": "187 vials", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Ogden", "state": "UT", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020171"], "brand_name": ["DELFLEX"], "generic_name": ["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"], "manufacturer_name": ["Fresenius Medical Care North America"], "product_ndc": ["49230-206", "49230-209", "49230-212"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "spl_id": ["38fafec0-59d7-1a67-e063-6294a90a8f1e"], "spl_set_id": ["bbc5b820-4973-11e2-a192-0002a5d5c51b"], "package_ndc": ["49230-206-20", "49230-206-30", "49230-206-32", "49230-206-50", "49230-206-60", "49230-206-62", "49230-206-52", "49230-209-23", "49230-209-30", "49230-209-32", "49230-209-50", "49230-209-60", "49230-209-62", "49230-209-52", "49230-212-23", "49230-212-30", "49230-212-32", "49230-212-50", "49230-212-60", "49230-212-62", "49230-212-52"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "87809", "recalling_firm": "Fresenius Medical Care, North America", "address_1": "475 W 13th St", "address_2": "N/A", "postal_code": "84404-5554", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0389-2021", "product_description": "Delflex Peritoneal Dialysis Solution with 1.5% Dextrose, LM/LC, packaged in a case containing 2 x 6 Liter bags, Rx only, NDC 49230-206-60, Fresenius Medical Care North America, Waltham, MA 02451", "product_quantity": "709 cases", "reason_for_recall": "Labeling; Label Mix-up; 4.25% DEXTROSE bag was found inside a 1.5% DEXTROSE box.", "recall_initiation_date": "20210414", "center_classification_date": "20210519", "termination_date": "20220405", "report_date": "20210526", "code_info": "Lot #20SU03019, Exp 6/2022"}, {"status": "Terminated", "city": "New Orleans", "state": "LA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90167", "recalling_firm": "Lula Holdings L.L.C.", "address_1": "1532 Saint Charles Ave", "address_2": "N/A", "postal_code": "70130-4446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "LA", "recall_number": "D-0859-2022", "product_description": "Kill 'Dat Sanitizing Products Hand Sanitizer, 1 gallon (128 fl. oz.) 80% Alcohol, OTC,  Manufactured by: Lula Holdings LLC, 15532 St. Charles Avenue, New Orleans, LA, NDC 77348-001-02.", "product_quantity": "192.78 pounds", "reason_for_recall": "CGMP Deviations: FDA analysis found product to contain acetaldehyde above specification limits.", "recall_initiation_date": "20220405", "center_classification_date": "20220511", "termination_date": "20240617", "report_date": "20220518", "code_info": "Batch 39"}, {"status": "Terminated", "city": "Minneapolis", "state": "MN", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "95736", "recalling_firm": "Padagis US LLC", "address_1": "3940 Quebec Ave N", "address_2": "N/A", "postal_code": "55427-1244", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0048-2025", "product_description": "Triamcinolone Acetonide Cream USP, 0.025%, 1 LB (454 g) per jar, Rx Only, Manufactured By Padagis, Minneapolis, MN 55427. NDC: 45802-0063-05", "product_quantity": "10,872 jars", "reason_for_recall": "Subpotent and Superpotent Drug. Out of specification assay results recorded as part of Uniformity of Container test during long-term stability testing.", "recall_initiation_date": "20241011", "center_classification_date": "20241118", "termination_date": "20250929", "report_date": "20241127", "code_info": "Lot #: 2024154238, 2024174344, Exp. Date 3/31/2026"}, {"status": "Terminated", "city": "West Deptford", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82298", "recalling_firm": "Johnson Matthey Inc.", "address_1": "2003 Nolte Dr", "address_2": "N/A", "postal_code": "08066-1727", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-1077-2019", "product_description": "Morphine Sulfate USP Milled, Active Pharmaceutical Ingredient, Rx only, Johnson Matthey Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, NJ 08066-1742", "product_quantity": "169.976 kg", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Bioburden out of specification results for Morphine Sulfate API.", "recall_initiation_date": "20180305", "center_classification_date": "20190403", "termination_date": "20210723", "report_date": "20190410", "code_info": "Lot# B1414-160809, Retest Date AUG 2021"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA076477"], "brand_name": ["ATORVASTATIN CALCIUM"], "generic_name": ["ATORVASTATIN CALCIUM"], "manufacturer_name": ["Sun Pharmaceutical Industries Inc."], "product_ndc": ["63304-827", "63304-828", "63304-829", "63304-830"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ATORVASTATIN CALCIUM TRIHYDRATE"], "rxcui": ["259255", "617310", "617311", "617312"], "spl_id": ["24508d3d-eec0-4c5c-bfaa-d6e01a03fe80"], "spl_set_id": ["595ab888-6b55-4642-a32f-e8521821ed81"], "package_ndc": ["63304-827-90", "63304-827-05", "63304-828-90", "63304-828-05", "63304-829-90", "63304-829-05", "63304-830-90", "63304-830-05"], "is_original_packager": [true], "unii": ["48A5M73Z4Q"]}, "product_type": "Drugs", "event_id": "63759", "recalling_firm": "Ranbaxy Inc.", "address_1": "600 College Rd E Ste 2100", "address_2": "N/A", "postal_code": "08540-6636", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and PR", "recall_number": "D-070-2013", "product_description": "Atorvastatin Calcium Tablets, 10 mg, 90 tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257, USA, by: Ranbaxy Laboratories Ltd., New Delhi - 110019, India, NDC #: 63304-827-90", "product_quantity": "120,201 Bottles", "reason_for_recall": "Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.", "recall_initiation_date": "20121109", "center_classification_date": "20121129", "termination_date": "20140428", "report_date": "20121205", "code_info": "Lot #s: 2436144, 2436582, 2441567, 2441568, Exp 08/31/2014."}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65019", "recalling_firm": "Nora Apothecary and Alternative Therapies, Inc.", "address_1": "1101 E 86th St", "address_2": "N/A", "postal_code": "46240-3729", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-456-2013", "product_description": "Papaverine Inj 30mg/ml Syr, 5mlsyr, 10mlsyr,10x0.95mlsyr  Penile Injection, 90 day expiration,", "product_quantity": "8", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.", "recall_initiation_date": "20130422", "center_classification_date": "20130529", "termination_date": "20140801", "report_date": "20130605", "code_info": "All products within their expiration date including those dated 90 days prior to April 19, 2013 (Jan. 2013 to April 19, 2013)."}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0907-2019", "product_description": "Safecare+ AllergyCare Homeopathic Non-Drowsy Taste-Free, Oral Spray, 1 fl oz (29.6 mL), UPC 357955404316, NDC 57955-4043-1", "product_quantity": "492 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 021717E Exp. 02/20; 091015R Exp. 09/18"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; carBAMazepine ER Tablet, 200 mg may be potentially mislabeled as    ACARBOSE, Tablet, 25 mg, NDC 00054014025, Pedigree: AD60272_1, EXP: 5/22/2014.", "address_2": "", "product_quantity": "200 Tablets", "code_info": "carBAMazepine ER, Tablet, 200 mg has the following code    Pedigree: AD60272_7, EXP: 5/22/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "carBAMazepine ER Tablet, 200 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 51672412401", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-604-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Vadodara", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA091117"], "brand_name": ["CEFTRIAXONE"], "generic_name": ["CEFTRIAXONE"], "manufacturer_name": ["Xellia Pharmaceuticals USA LLC"], "product_ndc": ["70594-098"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["CEFTRIAXONE SODIUM"], "rxcui": ["309090"], "spl_id": ["6f9223ec-bdaa-40a0-8a27-329aa27a50a7"], "spl_set_id": ["856be1ac-03a6-47be-b4a8-e9e8e7c87da5"], "package_ndc": ["70594-098-01"], "is_original_packager": [true], "unii": ["023Z5BR09K"]}, "product_type": "Drugs", "event_id": "92341", "recalling_firm": "Astral SteriTech Private Ltd.", "address_1": "911 G I D C Makarpura", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0620-2023", "product_description": "Ceftriaxone for Injection, USP 10 grams per Pharmacy Bulk Package, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-098-01", "product_quantity": "7,940 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20230515", "center_classification_date": "20230518", "termination_date": "20240405", "report_date": "20230524", "code_info": "All lots within expiry."}, {"country": "United States", "city": "Little Rock", "address_1": "1527 S Bowman Rd Ste D", "reason_for_recall": "Lack of Assurance of Sterility: Sterility of product is not assured.", "address_2": "", "product_quantity": "7 Bags", "code_info": "All product compounded between May 14, 2015 and May 27, 2015", "center_classification_date": "20150701", "distribution_pattern": "United States including: Arkansas", "state": "AR", "product_description": "TPN 2:1, 200 ml Bags, Qty: 7, Base Formula NaCl 0.9%, Dextrose 70%, Trophamine 10%, Water for Inj; Electrolytes Calcium Gluc, MgSO4, Na Phos, KCL; Vitamins, trace elements and medications Copper Cl, Selenium, Zinc Sulfate, Infuvite Pediat, Rx Only. Compounded by: United Medical IV Center (Little Rock) 1527 South Bowman Rd. Ste. D Little Rock, AR 72211-4200 501-227-0900.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Lincare, Inc.", "recall_number": "D-1158-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71415", "termination_date": "20170216", "more_code_info": "", "recall_initiation_date": "20150528", "postal_code": "72211-4200", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0118-2016", "product_description": "PROGESTERONE, Pellet, 50mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "5 pellets", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t10292014@22, t09022014@13, t08262014@11, t06192015@24, t05072014@11."}, {"country": "United States", "city": "Chino", "address_1": "4651 Schaefer Ave", "reason_for_recall": "CGMP Deviations: finished products were manufactured with poor quality water.", "address_2": "", "product_quantity": "5,148,792 pouches", "code_info": "Lot #: 7382A1, 7382B1, 7382A2, 7382B2, 7382A3, 7383A1, 7383B1, 7383A2, 7401A1, 7401B1, 7572A1, 7572B1, 7577B1, 7577A2, 7577B2, EXP 03/18; 7573B1, 7573A2, 7782A1, 7783A1, 7783B1, EXP 04/18; 7984B1, 7984A2, 7984B2, 8043A1, 8043B1, 8403A1, EXP 05/18; 8291A1, 8292B1, 8293A1, 8294B1, EXP 07/18; 8511A1, 8512B1, 8513B1, 8513A2, 8514A1, 8514B1, 8514A2, 8520A1, 8520B1, EXP 08/18; 8818A1, 8821B1, 8821A2, EXP 09/18", "center_classification_date": "20180416", "distribution_pattern": "Nationwide in the USA.", "state": "CA", "product_description": "WipeEssentials Wet Wipes (benzalkonium chloride 0.13%), 30-count pouches, Dist. by Diamond Wipes Int'l, Inc., Chino, CA  91710, UPC 7 66670 03988 6.", "report_date": "20180425", "classification": "Class II", "openfda": {}, "recalling_firm": "Diamond Wipes International, Inc.", "recall_number": "D-0630-2018", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "79758", "termination_date": "20190114", "more_code_info": "", "recall_initiation_date": "20180402", "postal_code": "91710-5542", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Woodbine", "state": "IA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "86690", "recalling_firm": "Grato Holdings, Inc.", "address_1": "201 Apple Blvd", "address_2": "N/A", "postal_code": "51579-1503", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "UT", "recall_number": "D-0099-2021", "product_description": "Homeopathic Energy Catalyst, 1 fl oz (30 mL) Distributed by: Deseret Biologicals, Inc. 469 W. Parkland Drive Sandy, UT 84070. NDC 43742-0756-1.", "product_quantity": "399 bottles", "reason_for_recall": "Labeling: Product Contains Undeclared API; Incorrect formulation", "recall_initiation_date": "20200917", "center_classification_date": "20201119", "termination_date": "20221018", "report_date": "20201125", "code_info": "Lot #s: Z60852, Z60012"}, {"status": "Terminated", "city": "East Bank Demerara", "state": "", "country": "Guyana", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69206", "recalling_firm": "New Gpc Inc.", "address_1": "Lot A1, Farm", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "New York", "recall_number": "D0031-2015", "product_description": "MUSTARCREME, Net Contents: 60g (21 oz)  Country of Origin Guyana.", "product_quantity": "1320 units", "reason_for_recall": "Does Not Meet Monograph: NEW GPC INC. has recalled multiple Over-the-Counter Drug Products due to lack of drug listing, lack of OTC drug labeling requirements and labeled Not Approved for sale in U.S.A..", "recall_initiation_date": "20140807", "center_classification_date": "20141017", "termination_date": "20180604", "report_date": "20141029", "code_info": "Batch Numbers: 305150, 312236, 311231", "more_code_info": ""}, {"status": "Terminated", "city": "Canonsburg", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021434"], "brand_name": ["ALPRAZOLAM"], "generic_name": ["ALPRAZOLAM"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["59762-0057", "59762-0059", "59762-0066", "59762-0068"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ALPRAZOLAM"], "rxcui": ["433798", "433799", "433800", "433801"], "spl_id": ["70f0098e-50b5-4e61-b4e0-141a55d92267"], "spl_set_id": ["1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3"], "package_ndc": ["59762-0057-1", "59762-0059-1", "59762-0066-1", "59762-0068-1"], "is_original_packager": [true], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["YU55MQ3IZY"]}, "product_type": "Drugs", "event_id": "90045", "recalling_firm": "Viatris Inc", "address_1": "1000 Mylan Blvd", "address_2": "N/A", "postal_code": "15317-5853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA", "recall_number": "D-0844-2022", "product_description": "alprazolam XR extended-release tablets, 3 mg, 60-count bottle, Rx only, Distributed by: Greenstone LLC, Peapack, NJ  07977, NDC 59762-0068-1.", "product_quantity": "6,789 bottles", "reason_for_recall": "Failed Dissolution Specifications: low out-of-specification dissolution test results observed.", "recall_initiation_date": "20220428", "center_classification_date": "20220503", "termination_date": "20230621", "report_date": "20220511", "code_info": "Lot # EH8348, exp. date August 2023"}, {"status": "Terminated", "city": "Conway", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82969", "recalling_firm": "Synthetopes Inc", "address_1": "216 Earnhardt St", "address_2": "N/A", "postal_code": "29526-8287", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1403-2019", "product_description": "Sn-d, l-Exametazime (Sn-d,l-HMPAO), Not for Direct Injection, Store Below 25 C, Synthetopes, Inc.", "product_quantity": "68 vials", "reason_for_recall": "Lack of Processing Controls.", "recall_initiation_date": "20190528", "center_classification_date": "20190620", "termination_date": "20201015", "report_date": "20190619", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Plattsburgh", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89059", "recalling_firm": "SterRx, LLC", "address_1": "141 Idaho Ave", "address_2": "", "postal_code": "12903-3987", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0318-2022", "product_description": "MORPHINE SULFATE, in 0.9% Sodium Chloride Injection, 50 mg per 50 mL, (1 mg per mL), Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-427-01.", "product_quantity": "880 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20211112", "center_classification_date": "20211229", "termination_date": "20231206", "report_date": "20220105", "code_info": "S21292/BYI", "more_code_info": ""}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0102-2016", "product_description": "METHIONINE/CHOLINE/INOSITOL, injectable Solution, 25/50/50 MG/ML, 10 mL syringes, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "2 syringes", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t03192015@20, t06012015@6, t04292015@18, t06192015@16, t07012015@26"}, {"status": "Terminated", "city": "Morristown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021116"], "brand_name": ["LEVOTHYROXINE SODIUM"], "generic_name": ["LEVOTHYROXINE SODIUM"], "manufacturer_name": ["Alvogen, Inc."], "product_ndc": ["47781-640", "47781-643", "47781-646", "47781-649", "47781-651", "47781-654", "47781-657", "47781-659", "47781-662", "47781-665", "47781-668", "47781-671"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LEVOTHYROXINE SODIUM"], "rxcui": ["892246", "892251", "892255", "966220", "966221", "966222", "966224", "966225", "966248", "966249", "966253", "966270"], "spl_id": ["810bfc86-7b45-4c14-bbaf-4c2e38aed4d3"], "spl_set_id": ["4ddcaec1-a58f-340b-9bc1-bbe048b8c885"], "package_ndc": ["47781-640-90", "47781-640-10", "47781-643-90", "47781-643-10", "47781-646-90", "47781-646-10", "47781-649-90", "47781-649-10", "47781-651-90", "47781-651-10", "47781-654-90", "47781-654-10", "47781-657-90", "47781-657-10", "47781-659-90", "47781-659-10", "47781-662-90", "47781-662-10", "47781-665-90", "47781-665-10", "47781-668-90", "47781-668-10", "47781-671-90", "47781-671-10"], "is_original_packager": [true], "upc": ["0347781649906", "0347781671907", "0347781643904", "0347781657901", "0347781640903", "0347781651909", "0347781662905", "0347781665906", "0347781646905", "0347781654900", "0347781659905"], "unii": ["9J765S329G"]}, "product_type": "Drugs", "event_id": "91654", "recalling_firm": "Alvogen, Inc", "address_1": "44 Whippany Rd Ste 107", "address_2": "N/A", "postal_code": "07960-4558", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico.", "recall_number": "D-0353-2023", "product_description": "Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc., Shenandoah, IA, 51601, Distributed by: Alvogen Inc, Pine Brook, NJ 07058, NDC 47781-654-90.", "product_quantity": "21,276 bottles", "reason_for_recall": "Sub-Potent Drug: Out of specification for assay at the 24 month interval.", "recall_initiation_date": "20230206", "center_classification_date": "20230224", "termination_date": "20240318", "report_date": "20230308", "code_info": "Lot # HE02221, Exp. 05/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Dawsonville", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89749", "recalling_firm": "Direct Rx", "address_1": "94 Worldwide Dr", "address_2": "N/A", "postal_code": "30534-6828", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, LA", "recall_number": "D-0650-2022", "product_description": "Alprazolam C-IV 1 mg 60-count bottles, Rx Only, Dist. By: Par Pharmaceutical Chestnut Ridge, NY 10977 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534, NDC 61919-836-60", "product_quantity": "16 bottles", "reason_for_recall": "CGMP Deviations: The Recall is due to the potential cross-contamination at the contract manufacturer (Ultra Tab Laboratories Inc.)", "recall_initiation_date": "20220304", "center_classification_date": "20220310", "termination_date": "20221202", "report_date": "20220316", "code_info": "Lot #: 19AU1910 Exp. 5/31/22"}, {"status": "Terminated", "city": "Longview", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88291", "recalling_firm": "Med Shop Total Care Inc.", "address_1": "470 E Loop 281", "address_2": "N/A", "postal_code": "75605-7939", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Texas and Puerto Rico", "recall_number": "D-0704-2021", "product_description": "BUPIVACAINE HCL-BACLOFEN PF INJECTABLE 40MG-4000MCG/ML, 21 mL syringe, Rx only, Med Shop Total Care 470 East Loop 281 Longview, TX 75605", "product_quantity": "21 mL", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20201005", "center_classification_date": "20210809", "termination_date": "20230817", "report_date": "20210818", "code_info": "Lot #: 09282020@94 BUD: 10/27/2020"}, {"status": "Ongoing", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86799", "recalling_firm": "Advanced Nutriceuticals, LLC", "address_1": "836 E 86th St", "address_2": "N/A", "postal_code": "46240-1806", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA, CO, FL, IN, KY, OH, TX", "recall_number": "D-0132-2021", "product_description": "BPC-157, 2000 MCG/ML, 5 ML vial, The Guyer Institute of Molecular Medicine, Indianapolis, IN", "product_quantity": "4 vials", "reason_for_recall": "Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.", "recall_initiation_date": "20201130", "center_classification_date": "20201211", "report_date": "20201223", "code_info": "Lot #1102202009, Exp 12/08/2020;  Lot #1105202009, Exp 12/20/2020;  Lot #1110202001, Exp 12/15/2020;  Lot #1112202004, Exp 12/12/2020"}, {"status": "Completed", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91466", "recalling_firm": "Sentara Infusion Services", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Dispensed to Patients Nationwide.", "recall_number": "D-0297-2023", "product_description": "IMIPENEM/CILASTATIN 2000MG IN NS 400ML, antibiotic, Rx Only, use with a Curlin Pump,  Sentara Home Infusion Pharmacy Services, 535 Independence Pkwy, Ste 300, Chesapeake, VA 23320, NDC#  63323-0322-25", "product_quantity": "7 bags", "reason_for_recall": "Lack of sterility assurance", "recall_initiation_date": "20221227", "center_classification_date": "20230215", "report_date": "20230222", "code_info": "Beyond Use Date: December 25-30, 2022"}, {"status": "Terminated", "city": "Albany", "state": "OR", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "89152", "recalling_firm": "Dental Alliance Holdings LLC", "address_1": "812 Water Ave Ne", "address_2": "", "postal_code": "97321-3074", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed nationwide with the United States", "recall_number": "D-0458-2022", "product_description": "CariFree sample boxes, contains one tube of CariFree CTx4 Gel 5000, 1.1% Neutral Sodium Fluoride Mint, 2 oz (57 g) Rx only NDC: 61578-205-01 Manufactured by Oral BioTech Albany, Oregon 97321.", "product_quantity": "8 single tubes of lot 492106 and 50 single tubes of lot 492107", "reason_for_recall": "Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.", "recall_initiation_date": "20211203", "center_classification_date": "20220126", "termination_date": "20220811", "report_date": "20220202", "code_info": "Lot #: 492106, 492107 Exp. Date 06/22 (contains recalled CariFree CTx4 5000 gel tube lot 142017).", "more_code_info": ""}, {"country": "United States", "city": "Noblesville", "address_1": "14450 Getz Rd", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "24", "code_info": "All Sterile Compounded Products within Expiry", "center_classification_date": "20160711", "distribution_pattern": "Nationwide        VA/DOD: CA, KY, MD, NC, OK, TX, VA", "state": "IN", "product_description": "Norepinephrine 16 mg added to 0.9% sodium Chloride, 250 mL bag, Rx Only, Compounded by PHARMAKON Pharmaceuticals, Noblesville, IN 46060,  NDC # 45183-0174-02", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Pharmakon Pharmaceuticals, Inc.", "recall_number": "D-1272-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73960", "termination_date": "20180111", "more_code_info": "", "recall_initiation_date": "20160420", "postal_code": "46060-3303", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: glyBURIDE MICRONIZED, Tablet, 3 mg may have potentially been mislabeled as the following drug:  DIGOXIN, Tablet, 0.125 mg, NDC 00115981101, Pedigree: W003154, EXP: 6/13/2014.", "address_2": "", "product_quantity": "101 Tablets", "code_info": "glyBURIDE MICRONIZED, Tablet, 3 mg has the following codes:   Pedigree: W003155, EXP: 6/13/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "glyBURIDE MICRONIZED, Tablet, 3 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00093803501.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-850-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72455", "recalling_firm": "Downing Labs, LLC", "address_1": "4001 McEwen Rd Suite 110", "address_2": "N/A", "postal_code": "75244-5020", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US; Australia, Brazil, Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, Phillippines, Singapore, Thailand, Trinidad and Tobago, Taiwan", "recall_number": "D-0339-2016", "product_description": "L-Tryptophan  Injectable, 30mg/mL, 30mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435", "product_quantity": "16 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151016", "center_classification_date": "20151118", "termination_date": "20160922", "report_date": "20151125", "code_info": "All lots"}, {"status": "Ongoing", "city": "Sinnar, Nashik District", "state": "N/A", "country": "India", "classification": "Class II", "openfda": {"application_number": ["ANDA078020"], "brand_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "generic_name": ["VALSARTAN AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-6321", "0378-6322", "0378-6323", "0378-6324", "0378-6325"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "VALSARTAN"], "rxcui": ["200284", "200285", "349353", "636042", "636045"], "spl_id": ["16044239-373d-4b04-9a4d-fd4232a93b6c"], "spl_set_id": ["3ba1f9f9-0037-4522-8605-e27dc8552b5b"], "package_ndc": ["0378-6321-77", "0378-6321-05", "0378-6322-77", "0378-6322-05", "0378-6323-77", "0378-6323-05", "0378-6324-77", "0378-6324-05", "0378-6325-77", "0378-6325-05"], "is_original_packager": [true], "upc": ["0303786323777"], "nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "unii": ["0J48LPH2TH", "80M03YXJ7I"]}, "product_type": "Drugs", "event_id": "81707", "recalling_firm": "Mylan Laboratories Limited, (Nashik FDF)", "address_1": "F-4 F-12, Malegaon M.I.D.C., Sinnar", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States to several major distributors, including Puerto Rico.", "recall_number": "D-0330-2019", "product_description": "Valsartan and Hydrochlorothiazide Tablets, USP 160/25 mg, (a) 90-count bottle (NDC 0378-6323-77), (b) 500-count bottles (NDC 0378-6323-05), Rx Only, Made in India, Manufactured for: Mylan Pharmaceuticals, Inc., Morgantown, WV 26505 U.S.A.", "product_quantity": "22,813 HDPE bottles", "reason_for_recall": "GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.", "recall_initiation_date": "20181204", "center_classification_date": "20181214", "report_date": "20181219", "code_info": "Lot numbers:  3084887    3093802    3084887    3084888    3093802"}, {"status": "Terminated", "city": "Southern Pines", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70656", "recalling_firm": "Health Innovations Pharmacy, Inc", "address_1": "295 Pinehurst Ave Bldg 2", "address_2": "N/A", "postal_code": "28387-7051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "NC", "recall_number": "D-1001-2015", "product_description": "Methylcobalamin 1000 mcg/mL Injection, Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.", "recall_initiation_date": "20150212", "center_classification_date": "20150508", "termination_date": "20170720", "report_date": "20150520", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Whippany", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "79555", "recalling_firm": "Bayer HealthCare Pharmaceuticals, Inc.", "address_1": "100 Bayer Blvd", "address_2": "N/A", "postal_code": "07981-1544", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0697-2018", "product_description": "All Alka-Seltzer Plus\u00bf packages with a full front panel instant Redeemable Coupon (IRC) affixed to the individual carton. The recalled products can be identified by checking the Bayer logo located on the lower left corner of the front of the carton. If the logo has an orange or green background, the product is included in the recall.", "product_quantity": "188,631 units", "reason_for_recall": "Labeling: Label Mix-Up: Bayer is recalling all Alka-Seltzer Plus packages, with a green or orange Bayer logo located on the lower left corner of the front of the carton, because the ingredients on the front sticker may not match the actual product in the carton.", "recall_initiation_date": "20180315", "center_classification_date": "20180424", "termination_date": "20200114", "report_date": "20180502", "code_info": "The recalled products can be identified by checking the Bayer logo located on the lower left corner of the front of the carton. If the logo has an orange or green background, the product is included in the recall"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0943-2020", "product_description": "BETAMETHASONE ACETATE/BETAMETHASONE (PF) Injectable Suspension, Betamethasone Acetate/Betamethasone (PF) CMC [10ML] 7MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0621-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 07092019+52610, Exp 2/6/2020; 07232019+52734, Exp 2/19/2020; 08282019+52853, 09042019+52878, 09102019+52903, Exp 3/2/2020; 09182019+52929, Exp 4/17/2020; 10092019+53082, Exp 2/28/2020, 10152019+53124; Exp 5/4/2020; 10222019+53142, Exp 2/28/2020; 10292019+53160, 11052019+53186, Exp 5/4/2020; 11202019+53257, Exp 6/19/2020; 11212019+53270, Exp 6/20/2020; 12042019+53317, Exp 7/3/2020; 12102019+53363, Exp 7/9/2020"}, {"status": "Completed", "city": "Bentonville", "state": "AR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90359", "recalling_firm": "Walmart Inc", "address_1": "702 Sw 8th St Ms 275", "address_2": "", "postal_code": "72716-6299", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-1158-2022", "product_description": "Artri Ajo King Reforzado con Ortiga y Omega 3 Tablets, ORIGINAL, 100-count bottles, UPC 7 501031 12705.", "product_quantity": "1308 bottles total", "reason_for_recall": "Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.", "recall_initiation_date": "20220524", "center_classification_date": "20220624", "report_date": "20220622", "code_info": "All product lots.", "more_code_info": ""}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0395-2017", "product_description": "Sermorelin Acetate/GHRP (2) 9 mg/3 mg Injectable Kit, Compounded by Wells Pharmacy, Ocala FL", "product_quantity": "2,264 kits (number of vials per kit vary by prescription)", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code: 04152016@149, 05182016@176, 06172016@142, 07272016@83, 08232016@32, 09122016@138.  Known vial lot code: 04072016@91, 04262016@27, 05272016@41, 07192016@29, 08192016@18, 09062016@44."}, {"status": "Terminated", "city": "Pulaski", "state": "TN", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86940", "recalling_firm": "AVKARE Inc.", "address_1": "615 N 1st St", "address_2": "N/A", "postal_code": "38478-2403", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the U.S.", "recall_number": "D-0168-2021", "product_description": "TraZODONE Hydrochloride Tablets USP 100 mg, Rx Only, 1000-count Bottle, Manufactured for: AvKARE Pulaski, TN 38478, NDC 42291-834-10", "product_quantity": "14368 bottles", "reason_for_recall": "Product mix-up: Bottles of sildenafil and trazodone were inadvertently packaged together during bottling at a 3rd party facility.", "recall_initiation_date": "20201207", "center_classification_date": "20201216", "termination_date": "20231016", "report_date": "20201223", "code_info": "Lot: 36783 Exp. 06/2022"}, {"status": "Terminated", "city": "Los Angeles", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84978", "recalling_firm": "Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical", "address_1": "1990 Westwood Blvd Ste 135", "address_2": "N/A", "postal_code": "90025-4650", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic", "recall_number": "D-0971-2020", "product_description": "Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10ML] CMC 100 MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0619-1", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20200115", "center_classification_date": "20200305", "termination_date": "20231207", "report_date": "20200311", "code_info": "Lot #: 06122019+52423, Exp 7/9/2020; 06122019+52420, Exp 7/9/2020; 07182019+52703, Exp 8/14/2020"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0968-2023", "product_description": "vancomycin 1.5 g/250mL added to 5% dextrose, 6 mg/mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6075-1", "product_quantity": "2,914 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-239516, 36-239517, Exp. 7/12/2023; 36-239989, Exp. 7/13/2023; 36-240798, Exp. 7/17/2023; 36-241133, Exp. 7/19/2023; 36-241981, Exp. 7/24/2023; 36-242717, Exp. 7/26/2023; 36-245577, Exp. 8/2/2023."}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0063-2015", "product_description": "Benzalkonium chloride water for injection packaged in an amber glass injectable vial, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "30 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 04292014@19, Exp 10/26/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Athens", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83074", "recalling_firm": "RXQ Compounding LLC", "address_1": "340 W State St Unit 9", "address_2": "N/A", "postal_code": "45701-1564", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA", "recall_number": "D-1686-2019", "product_description": "MORPHINE 1MG/ML IN NACL 0.9% 55ML SYR (C-II), 55 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0138-89", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190619", "center_classification_date": "20190808", "termination_date": "20220916", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA090694"], "brand_name": ["DULOXETINE"], "generic_name": ["DULOXETINE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-294", "68180-295", "68180-296", "68180-297"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DULOXETINE HYDROCHLORIDE"], "rxcui": ["596926", "596930", "596934", "616402"], "spl_id": ["7ad45dfa-a630-4e5f-85c0-25dc9e8bfbb7"], "spl_set_id": ["829a4f51-c882-4b64-81f3-abfb03a52ebe"], "package_ndc": ["68180-294-07", "68180-294-03", "68180-294-09", "68180-294-06", "68180-295-06", "68180-295-09", "68180-295-03", "68180-296-03", "68180-296-06", "68180-296-09", "68180-297-06", "68180-297-09", "68180-297-03", "3681802950"], "is_original_packager": [true], "upc": ["0368180296065", "0368180297062", "0368180295068", "368180295068"], "unii": ["9044SC542W"]}, "product_type": "Drugs", "event_id": "78596", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "N/A", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0097-2018", "product_description": "Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited Goa 403 722 India, NDC 68180-295-06, UPC 368180295068", "product_quantity": "111,648 units", "reason_for_recall": "Failed Dissolution Specification", "recall_initiation_date": "20171121", "center_classification_date": "20171128", "termination_date": "20190415", "report_date": "20171206", "code_info": "Lot #: G602051, Exp. 12/2017"}, {"status": "Terminated", "city": "Southern Pines", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70656", "recalling_firm": "Health Innovations Pharmacy, Inc", "address_1": "295 Pinehurst Ave Bldg 2", "address_2": "N/A", "postal_code": "28387-7051", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "NC", "recall_number": "D1051-2015", "product_description": "Phen 15 mg - Topri 92 mg SR Cap (Qsymia), Health Innov Pharmacy, 295 Pinehurst Ave, Southern Pines, NC 28387, (910) 246-5155", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Stability Data does not Support Expiry: recent inspection observations associated with certain quality control procedures that present a risk to sterility and quality assurance.", "recall_initiation_date": "20150212", "center_classification_date": "20150508", "termination_date": "20170720", "report_date": "20150520", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA202164"], "brand_name": ["PRAMIPEXOLE DIHYDROCHLORIDE"], "generic_name": ["PRAMIPEXOLE DIHYDROCHLORIDE"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "product_ndc": ["33342-031", "33342-032", "33342-033", "33342-034", "33342-035"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["PRAMIPEXOLE DIHYDROCHLORIDE"], "spl_id": ["721c81fc-fd21-4d86-ab96-9a329b8e015b"], "spl_set_id": ["b8c94917-73a1-44c2-8fd8-07f45054176b"], "package_ndc": ["33342-031-10", "33342-031-15", "33342-031-06", "33342-031-12", "33342-032-10", "33342-032-15", "33342-032-06", "33342-032-12", "33342-033-10", "33342-033-15", "33342-033-06", "33342-033-12", "33342-034-10", "33342-034-15", "33342-034-06", "33342-034-12", "33342-035-10", "33342-035-15", "33342-035-06", "33342-035-12"], "is_original_packager": [true], "upc": ["0333342031105", "0333342035103", "0333342034106", "0333342033109", "0333342032102"], "unii": ["3D867NP06J"]}, "product_type": "Drugs", "event_id": "83597", "recalling_firm": "Macleods Pharma Usa Inc", "address_1": "666 Plainsboro Rd Bldg 200 Ste 230", "address_2": "", "postal_code": "08536-0009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-1851-2019", "product_description": "Pramipexole Dihydrochloride Tablets 0.125 mg,90-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Plainsboro, NJ 08536,  Manufactured by: Macleods Phamaceuticals Ltd. Baddi Himachal Pradesh, India. NDC 33342-031-10", "product_quantity": "1837 90-count bottles", "reason_for_recall": "Subpotent Drug: Out of specification result during stability study in Pramipexole Dihydrochloride Tablets 0.125 mg", "recall_initiation_date": "20190821", "center_classification_date": "20190911", "termination_date": "20210128", "report_date": "20190918", "code_info": "Lot #BPA801A, EXP 12/2020", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup:CYANOCOBALAMIN, Tablet, 500 mcg was mislabled as SEVELAMER CARBONATE, Tablet, 800 mg, NDC 58468013001, Pedigree: W002859, EXP: 6/7/2014.  and may have potentially been mislabeled as one of the following drugs:  VITAMIN B COMPLEX W/C, Tablet, 0, NDC 00536730001, Pedigree: AD52993_7, EXP: 5/20/2014;  CYANOCOBALAMIN, Tablet, 1000 mcg, NDC 00536355601, Pedigree: AD30180_22, EXP:", "address_2": "", "product_quantity": "700 Tablets", "code_info": "CYANOCOBALAMIN, Tablet, 500 mcg has the following codes:   Pedigree: AD52993_19, EXP: 5/20/2014;  Pedigree: AD30180_25, EXP: 5/9/2014;  Pedigree: AD37056_10, EXP: 5/10/2014;  Pedigree: AD60578_16, EXP: 5/29/2014;  Pedigree: W002860, EXP: 6/7/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "CYANOCOBALAMIN, Tablet, 500 mcg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00536355101.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-932-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "5-Fluorouracil pf in methocel 1% opthal", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1112-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85341", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Other", "distribution_pattern": "Products are sold online within the United States and  internationally to the following countries: Australia, Canada, Israel, Italy, Japan, Norway, and United Kingdom", "recall_number": "D-1106-2020", "product_description": "Acne Cystic, 500 mg Capsules, 90-count bottles, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: These products have been found to be misbranded as  unapproved new drugs", "recall_initiation_date": "20200324", "center_classification_date": "20200407", "termination_date": "20240125", "report_date": "20200415", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Saint Louis", "state": "MO", "country": "United States", "classification": "Class III", "openfda": {"brand_name": ["DRY EYE TEST"], "generic_name": ["FLUORESCEIN SODIUM"], "manufacturer_name": ["Nomax Inc."], "product_ndc": ["51801-008"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["FLUORESCEIN SODIUM"], "spl_id": ["7490418c-b489-4b90-bc3d-33ed71231e2d"], "spl_set_id": ["04866053-f973-471e-b3bc-241fb76303a2"], "package_ndc": ["51801-008-15"], "is_original_packager": [true], "unii": ["93X55PE38X"]}, "product_type": "Drugs", "event_id": "87695", "recalling_firm": "Nomax Inc", "address_1": "9735 Green Park Industrial Dr", "address_2": "N/A", "postal_code": "63123-7241", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0387-2021", "product_description": "Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100 Sterile Strips (50 Pouches of 2 Strips Each), Manufactured by: Nomax, Inc, St. Louis, MO 63123, NDC: 51801-008-15", "product_quantity": "78 cartons", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20210413", "center_classification_date": "20210518", "termination_date": "20230928", "report_date": "20210526", "code_info": "LOT 13336 EXP 07/23"}, {"status": "Ongoing", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "94842", "recalling_firm": "Accord Healthcare, Inc.", "address_1": "1009 Slater Rd Ste 210B", "address_2": "N/A", "postal_code": "27703-8446", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0580-2024", "product_description": "Dodex Injectable (Cyanocobalamin Injection) USP, 1,000mcg/mL, 1mL multiple dose vial, Rx only, Manufactured for: Accord Healthcare, Inc., Durham, NC 27703, Manufactured by: Intas Pharmaceuticals Limited, Ahmedabad-382 210, India, NDC 16729-533-08, UPC Code: 031672953308", "product_quantity": "52,998", "reason_for_recall": "Subpotent drug: out of specification results", "recall_initiation_date": "20240618", "center_classification_date": "20240702", "report_date": "20240710", "code_info": "Lot# R2200834, R2200835, R2200841, R2200958, Exp 06/30/2024; R2201044    R2201045    R2201046, R2201047, R2201095, R2201142, R2201143, R2201144, Exp 07/31/2024; M2215870, M2215918, Exp 10/2024"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1030-2022", "product_description": "Spinal Tray (A4058-25 Spinal Tray 25G Whitacre No Epinephrine), Rx only, Manufacturer: Smiths Medical ASD, Inc., NJ", "product_quantity": "8 cases", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 137 mcg may have potentially been mislabeled as the following drug:  ISONIAZID, Tablet, 300 mg, NDC 00555007102, Pedigree: AD60272_70, EXP: 5/22/2014.", "address_2": "", "product_quantity": "100 Tablets", "code_info": "LEVOTHYROXINE SODIUM, Tablet, 137 mcg has the following codes:   Pedigree: AD60272_76, EXP: 5/22/2014.", "center_classification_date": "20140120", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "LEVOTHYROXINE SODIUM, Tablet, 137 mcg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00527163801.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-924-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65690", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0151-2022", "product_description": "TEST CYPIONATE 200MG/ANASTROZOLE 0.5MG/DUTASTERIDE 0.5MG/ML IN OIL  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "23 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot:  07292021:54 BUD: 01/25/2022; T1006302021:96 BUD: 12/27/2021; T1008092021:60 BUD: 02/05/2022; T1009222021:51 BUD: 03/21/2022;  T1006082021:79 BUD: 12/05/2021; T1008302021:82 BUD: 02/26/2022;", "more_code_info": ""}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83789", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0078-2020", "product_description": "NEOstigmine Methylsulfate (PF), 5 mg/5 mL (1 mg/mL), 5 mL fill in a 6 mL Single Dose Syringe, Rx Only, KRS Global Biotechnology 791 Park of Commerce Blvd, Boca Raton, FL 33487. NDC 3321678303", "product_quantity": "3410 syringes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190912", "center_classification_date": "20191001", "termination_date": "20210819", "report_date": "20191009", "code_info": "All lots remaining within expiry."}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64821", "recalling_firm": "West-ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-242-2013", "product_description": "Ethambutol Hydrochloride Tablets, USP, 100 mg, 100-count tablets per bottle, Rx only, Mfd. for: Versapharm Incorporated, Marietta, GA;  Mfd. by: West-Ward Pharmaceutical Corp., Eatontown, NJ 07724; NDC 61748-011-01.", "product_quantity": "3, 061 bottles", "reason_for_recall": "Subpotent Drug: Out Of Specification results for assay at the stability time-point of 24 months.", "recall_initiation_date": "20130318", "center_classification_date": "20130403", "termination_date": "20131218", "report_date": "20130410", "code_info": "Lot #: 68028A, Exp 07/14"}, {"status": "Terminated", "city": "Allentown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73336", "recalling_firm": "Walter's Pharmacy", "address_1": "401 N 17th St", "address_2": "N/A", "postal_code": "18104-5034", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "PA", "recall_number": "D-0792-2016", "product_description": "Vancomycin 25mg/mL Solution, 10 mL bottles, Rx only, Walter's Pharmacy 401 N 17th St., Allentown, PA 610-435-4706, NDC 99999-9003-78", "product_quantity": "4 bottles", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160212", "center_classification_date": "20160329", "termination_date": "20170106", "report_date": "20160406", "code_info": "Lot #: 012216, 012616, 012816, 020316, 020616;"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0111-2016", "product_description": "PAPAVERINE/PHENTOLAMINE, Injectable Solution, 30MG/1MG/ML, 10 mL syringe,  Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "8 syringes", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t09172014@29, t08252014@1, t06082015@10, t03032015@26, t02272015@23, t01232015@12, t01122015@36, t05132015@15"}, {"status": "Terminated", "city": "Brooklyn", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83136", "recalling_firm": "Infusion Options, Inc.", "address_1": "5924 13th Ave", "address_2": "N/A", "postal_code": "11219-4934", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "NY only", "recall_number": "D-1814-2019", "product_description": "TOPOTECAN 1.24 MG / 100 ML NS IVPB, Rx Only, Infusion Options, Inc. 5924 13the Ave, Brooklyn, NY 11219-4934, 718-283-7233", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190612", "center_classification_date": "20190815", "termination_date": "20250321", "report_date": "20190821", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Weeki Wachee", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "79803", "recalling_firm": "Premier Pharmacy Labs Inc", "address_1": "8265 Commercial Way", "address_2": "N/A", "postal_code": "34613-4511", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0702-2018", "product_description": "NEOstigmine Methylsulfate (1 mg/mL) 3mg per 3mL. 3mL Single Dose Syringe. Premier Pharmacy Labs. 8265 Commercial Way  Weeki Wachee, FL 34613 NDC 69623-234-14.", "product_quantity": "600 syringes", "reason_for_recall": "Lack of Assurance of Sterility:Microbial contamination was detected during routine testing of subsequent unreleased product lots due to interaction between the product syringe and tamper evident container closure, which may result in the potential introduction of microorganisms into the products.", "recall_initiation_date": "20180411", "center_classification_date": "20180426", "termination_date": "20200915", "report_date": "20180502", "code_info": "Lot: NEO022218SVDS BUD: 8/21/2018"}]